The Price Is the Strategy: What Nineteen Launches Taught Me About Pricing in Life Sciences
Most organizations treat pricing as the last commercial decision because they believe the market will tell them what the product is worth. The market will — but what it reports is perceived value, not true economic value. The gap between the two is where pricing strategy lives.
Market Access as a Commercial Strategy Discipline: What Nineteen Launches Taught Me About the Payer Conversation
Market access is not a commercial function. It is a commercial condition — the gate through which a product's clinical profile, pricing strategy, and communication architecture must pass before any of it reaches the patient.
Read the System, Build the Evidence, Lead the Decision
The most useful strategic judgment I know didn't come from a classroom, a framework, or a single industry. It came from having to learn four completely different systems under real pressure, with real consequences each time for getting it wrong.
